Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794270 · ClinicalTrials.gov registry record · NA
Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT04794270 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 72 participants.
The verdict
NCT04794270, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This is a bilateral, dispensing, randomized, controlled, double-masked, 2×2 cross-over study to evaluate the clinical performance of ACUVUE OASYS® 1-Day for Astigmatism contact lenses produced on a recently qualified manufacturing line.
Interventions
- DEVICE ACUVUE OASYS® 1-Day for Astigmatism - TAM 24
- DEVICE ACUVUE OASYS® 1-Day for Astigmatism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2021-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04794270
The ClinicalTrials.gov registry entry for NCT04794270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACUVUE OASYS® 1-Day for Astigmatism - TAM 24 is the first listed.
NCT04794270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04794270 about?
NCT04794270 is a clinical study titled "Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line". This is a bilateral, dispensing, randomized, controlled, double-masked, 2×2 cross-over study to evaluate the clinical performance of ACUVUE OASYS® 1-Day for Astigmatism contact lenses produced on a recently qualified manufacturing line.
What is the current status of trial NCT04794270?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-03-02. Estimated completion is 2021-04-13.
What interventions are being tested in trial NCT04794270?
The interventions under investigation include: ACUVUE OASYS® 1-Day for Astigmatism - TAM 24 (DEVICE), ACUVUE OASYS® 1-Day for Astigmatism (DEVICE).
Who is sponsoring clinical trial NCT04794270?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.